Need for a new Lyme disease vaccine

New England Journal of Medicine

Volumn 375, Issue 10, 2016, Pages 911-913

  Plotkin, Stanley A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Vaxconsult   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER SURFACE PROTEIN A; BACTERIAL VACCINE; BACTERIUM ANTIBODY; LIPOPROTEIN; LYME DISEASE VACCINE; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN;

ARTHRITIS; BORRELIA BURGDORFERI; CARBOXY TERMINAL SEQUENCE; CARDITIS; DRUG EFFICACY; DRUG SAFETY; FACIAL NERVE PARALYSIS; HUMAN; LYME DISEASE; MENINGITIS; MYALGIA; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; VACCINATION; AGE DISTRIBUTION; ANIMAL; GENETICS; IMMUNOLOGY; SEROTYPE;

AGE DISTRIBUTION; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; HUMANS; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; SEROGROUP; UNITED STATES;

EID: 84986592844     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1607146     Document Type: Short Survey

References (5)

1. Sykes RA, Makiello P. An estimate of Lyme borreliosis incidence in Western Europe. J Public Health (Oxf) 2016 March 9 (Epub ahead of print).
2. Livey I, O'Rourke M, Traweger A, et al. A new approach to a Lyme disease vaccine. Clin Infect Dis 2011;52:Suppl 3:s266-70.
3. Comstedt P, Hanner M, Schüler W, Meinke A, Lundberg U. Design and development of a novel vaccine for protection against Lyme borreliosis. PLoS One 2014;9(11):e113294.
4. Koide S, Yang X, Huang X, Dunn JJ, Luft BJ. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA. J Mol Biol 2005;350:290-9.
5. Earnhart CG, Marconi RT. An octavalent Lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences. Hum Vaccin 2007;3:281-9.